Quality Reliability Technology (405100) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
15 Jul, 2026Executive summary
Provides reliability evaluation and comprehensive analysis services for semiconductors and electronic components, with a focus on advanced testing equipment and R&D for high-reliability markets.
Operates globally with subsidiaries in Hong Kong, China, and the USA, and is listed on KOSDAQ since 2022.
Major shareholder is the CEO, holding 59.6% of shares as of September 2024.
Financial highlights
2024 Q3 cumulative revenue: ₩45.99 billion, down from ₩53.26 billion in 2023 Q3.
Operating income for 2024 Q3: ₩3.06 billion, up from ₩752 million in 2023 Q3.
Net income for 2024 Q3: ₩2.77 billion, down from ₩3.90 billion in 2023 Q3.
Cash and cash equivalents at Q3-end: ₩20.25 billion.
Total assets: ₩135.19 billion; total equity: ₩93.05 billion.
Outlook and guidance
Anticipates increased demand for reliability testing in AI, 5G, automotive, and aerospace sectors.
Market recovery expected in memory semiconductors and continued growth in AI and system semiconductors.
Ongoing R&D investment in advanced reliability equipment and expansion into new high-growth markets.
Latest events from Quality Reliability Technology
- H1 2026 revenue up 18.8% YoY, net income KRW 3.8B, strong equipment sales growth.405100
Q2 2026 - 2024 H1 revenue reached ₩29.5B with ₩1.4B net income, led by reliability testing services.405100
Q2 2024 - 2024 revenue up 23% and operating income up 534%, driven by advanced semiconductor testing.405100
Q4 2024 - FY2025 revenue rose 5.5% to KRW 68.9B, driven by advanced semiconductor reliability demand.405100
Q4 2025 - Q1 2026 revenue up 32.7% and net income up 779.7% year-over-year, driven by reliability testing demand.405100
Q1 2026 - 2025 Q3 revenue and profit declined, but R&D investment and equity remain strong.405100
Q3 2025 - Q1 2025 revenue and net income grew on robust semiconductor reliability testing demand.405100
Q1 2025 - H1 2025 revenue reached KRW 32.75B with 17.3% of sales invested in R&D.405100
Q2 2025